All In Biotech

Drug Trial Radar · NCT07573462

A Study to Learn About the Safety of an Expanded Pneumococcal Vaccine in Healthy Infants

A PHASE 3, RANDOMIZED, DOUBLE-BLINDED TRIAL TO EVALUATE THE SAFETY AND TOLERABILITY OF A MULTIVALENT PNEUMOCOCCAL CONJUGATE VACCINE IN HEALTHY INFANTS

Last checked: Nov 19, 2026Latest source record: Nov 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 2,400 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

2,400

Planned (sponsor's estimate)

Start

May 4, 2026

Primary completion

Dec 30, 2028

Study completion Dec 30, 2028

Sponsor

Lead sponsor
PfizerPfizer (PFE)
Sponsor type
Industry
First posted
May 7, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Prevention
FDA-regulated drug
Yes
Who can join
All sexes, from 42 days, up to 98 days
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The purpose of this study is to learn about the safety of a new pneumococcal vaccine and how the new pneumococcal vaccine helps to fight against germs that can cause pneumonia (lung infections), meningitis (brain infections), and otitis media (ear infections) in infants when compared to the pneumococcal vaccine that is currently in use, 20vPnC (Prevnar 20®). This study will test if the new pneumococcal vaccine is as safe as the one that is currently in use. This new vaccine can possibly provide additional protection against germs that cause pneumococcal disease that are not included in the vaccines that are currently given to infants. Pneumococcal disease includes a variety of infections caused by a specific germ, Streptococcus pneumoniae. There are two groups in this study. All participants will be assigned to one of the two groups. This study is seeking participants who are: \- infants who are about 2 months of age About 2400 infants will be assigned by chance to one of the two groups to receive either PG4 (new vaccine) or 20vPnC (currently in use) into the left thigh muscle at 2, 4, 6, and 12 to 15 months of age. Infants will take part in this study for about 16 to 19 months (about 1 and a half years). During this time, infants will have 6 study clinic visits and 1 phone call. At these study clinic visits, parent(s)/legal guardian(s) will be asked if the infant experienced any side effects. A side effect is an unintentional or unexpected reaction to a vaccine.

Conditions

  • Pneumococcal Disease

Interventions

  • PG4Biological

    Multivalent Pneumococcal Vaccine

  • 20-valent pneumococcal conjugate vaccine (20vPnC)Biological

    20-valent pneumococcal conjugate vaccine (20vPnC)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of participants reporting local reactions within 7 days after each doseTime frame: Day 7
  2. Percentage of participants reporting systemic events within 7 days after each doseTime frame: Day 7
  3. Percentage of participants reporting adverse events (AEs) from Dose 1 to 1 month after Dose 3Time frame: Dose 1 to 1 month after Dose 3
  4. Percentage of participants reporting AEs from Dose 4 to 1 month after Dose 4Time frame: Dose 4 to 1 month after Dose 4
  5. Percentage of participants reporting serious adverse events (SAEs)Time frame: Dose 1 to 6 months after Dose 4

Locations

91 sites in 11 countries. Site status is shown where the registry gives one.

  • Starz Pediatrics

    Estero, Florida · Recruiting

  • Innovate Research Centers, LLC

    Fort Lauderdale, Florida · Recruiting

  • MacKoul Pediatrics Fort Myers

    Fort Myers, Florida · Recruiting

  • Speranza Research Center

    Hialeah, Florida · Recruiting

  • Dr. Gala, LLC

    Miami, Florida · Recruiting

  • Rophe Adult and Pediatric Medicine/SKYCRNG

    Union City, Georgia · Recruiting

  • Rosemark Women Care Specialists

    Idaho Falls, Idaho · Recruiting

  • Eagle Clinical Research

    Chicago, Illinois · Recruiting

  • Kentucky Pediatric/ Adult Research

    Bardstown, Kentucky · Recruiting

  • LSU Health Shreveport Clinical Trials Office

    Shreveport, Louisiana · Recruiting

  • Ochsner LSU Health - Progressive Pediatrics

    Shreveport, Louisiana · Recruiting

  • Ochsner LSU Health Shreveport Academic Medical Center

    Shreveport, Louisiana · Recruiting

  • Ochsner LSU Health Shreveport Ambulatory Care Center

    Shreveport, Louisiana · Recruiting

  • Pediatric Associates of Fall River

    Fall River, Massachusetts · Recruiting

  • Lincoln Pediatric Group

    Lincoln, Nebraska · Recruiting

  • Boston Children's Health Physicians

    Hawthorne, New York · Recruiting

  • Maria Fareri Children's Hospital

    Valhalla, New York · Recruiting

  • Senders Pediatrics

    South Euclid, Ohio · Recruiting

  • Legacy Clinical Trials

    Oklahoma City, Oklahoma · Recruiting

  • Cyn3rgy Research Corporation

    Gresham, Oregon · Recruiting

  • Donald Guthrie Foundation

    Sayre, Pennsylvania · Recruiting

  • Guthrie Medical Group

    Sayre, Pennsylvania · Recruiting

  • Tribe Clinical Research LLC. at Parkside Pediatrics Five Forks

    Simpsonville, South Carolina · Recruiting

  • Vast Clinical Research - Ivy Children's Clinic

    Euless, Texas · Not yet recruiting

  • National Research Centers, Plano LLC

    Plano, Texas · Recruiting

  • Pediatric Research of Charlottesville, LLC.

    Gordonsville, Virginia · Recruiting

  • Instituto Médico Río Cuarto

    Río Cuarto, Córdoba Province, Argentina · Not yet recruiting

  • Clínica Mayo de Urgencias Médicas Cruz Blanca S.R.L

    San Miguel de Tucumán, Tucumán Province, Argentina · Not yet recruiting

  • Hospital del Niño Jesus

    San Miguel de Tucumán, Tucumán Province, Argentina · Not yet recruiting

  • The Children's Hospital at Westmead

    Westmead, New South Wales, Australia · Recruiting

  • Queensland Children's Hospital

    Brisbane, Queensland, Australia · Recruiting

  • Centre for Children's Health Research

    South Brisbane, Queensland, Australia · Recruiting

  • Monash Health

    Clayton, Victoria, Australia · Recruiting

  • Murdoch Children's Research Institute

    Parkville, Victoria, Australia · Recruiting

  • Perth Children's Hospital

    Nedlands, Western Australia, Australia · Recruiting

  • The Kids Research Institute Australia

    Nedlands, Western Australia, Australia · Recruiting

  • CHU de Quebec - Universite Laval

    Québec, Canada · Not yet recruiting

  • Centre Hospitalier Universitaire Laval

    Québec, Canada · Not yet recruiting

  • Milestone Research Inc.

    London, Ontario, Canada · Recruiting

  • Bluewater Clinical Research Group Inc.

    Sarnia, Ontario, Canada · Recruiting

Showing 40 of 91 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.